• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信号转导衔接蛋白2通过阻止终末效应分化促进功能性长期记忆CD8 + T细胞的产生。

Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation.

作者信息

Muraoka Daisuke, Seo Naohiro, Hayashi Tae, Hyuga-Amaike Chisaki, Okamori Kana, Tawara Isao, Harada Naozumi, Shiku Hiroshi

机构信息

Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Mie, Japan.

Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.

出版信息

Oncotarget. 2017 May 9;8(19):30766-30780. doi: 10.18632/oncotarget.15403.

DOI:10.18632/oncotarget.15403
PMID:28430604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5458166/
Abstract

Long-surviving memory CD8+ T cells generated by stimulation with appropriate tumor-associated antigens are the most aggressive and persistent tumoricidal effectors. In this event of memory CD8+ T cell development, the signal transducer and activator of transcription (STAT) proteins function as the crucial intracellular signaling molecules, but the regulatory mechanism of STATs in CD8+ T cells is not fully understood. In this study, we report for the first time, by using murine vaccination models, that signal-transducing adaptor protein-2 (STAP2) maintains the cytotoxicity of long-lived memory CD8+ T cells by controlling a STAT3/suppressor of cytokine signaling 3 (SOCS3) cascade. Following T cell activation, STAP2 expression was transiently reduced but was subsequently recovered and augmented. Analysis using small-interfering RNA (siRNA) demonstrated that restored STAP2 expression was associated with the activation of STAT3/SOCS3 signals and maintenance of cytotoxic T lymphocytes (CTLs) secondary responses by preventing their differentiation into terminal effector cells. Notably, this STAP2-dependent memory differentiation was observed in the spleen, but not in the lymph nodes (LNs). These findings indicate an essential role for STAP2 in the generation of a high-quality memory CD8+ CTLs periphery, and suggest the therapeutic potential of STAP2 in cancer patients.

摘要

通过用适当的肿瘤相关抗原刺激产生的长期存活的记忆性CD8 + T细胞是最具攻击性和持久性的杀瘤效应细胞。在记忆性CD8 + T细胞发育过程中,信号转导及转录激活蛋白(STAT)发挥关键的细胞内信号分子作用,但STATs在CD8 + T细胞中的调控机制尚未完全明确。在本研究中,我们首次利用小鼠疫苗接种模型报道,信号转导衔接蛋白2(STAP2)通过控制STAT3 /细胞因子信号转导抑制因子3(SOCS3)级联反应来维持长寿记忆性CD8 + T细胞的细胞毒性。T细胞活化后,STAP2表达短暂降低,但随后恢复并增强。使用小干扰RNA(siRNA)进行的分析表明,恢复的STAP2表达与STAT3 / SOCS3信号的激活以及通过防止细胞毒性T淋巴细胞(CTLs)分化为终末效应细胞来维持其二次反应有关。值得注意 的是,这种依赖STAP2的记忆分化在脾脏中观察到,而在淋巴结(LN)中未观察到。这些发现表明STAP2在高质量记忆性CD8 + CTLs外周生成中起重要作用,并提示STAP2在癌症患者中的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/f5e69ff8ad9a/oncotarget-08-30766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/4d75c263b2f1/oncotarget-08-30766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/203339005de5/oncotarget-08-30766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/cd50ea4fef0c/oncotarget-08-30766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/d5013f711b34/oncotarget-08-30766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/7c895f511f83/oncotarget-08-30766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/d1d8c0d60f46/oncotarget-08-30766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/f5e69ff8ad9a/oncotarget-08-30766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/4d75c263b2f1/oncotarget-08-30766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/203339005de5/oncotarget-08-30766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/cd50ea4fef0c/oncotarget-08-30766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/d5013f711b34/oncotarget-08-30766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/7c895f511f83/oncotarget-08-30766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/d1d8c0d60f46/oncotarget-08-30766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01e3/5458166/f5e69ff8ad9a/oncotarget-08-30766-g007.jpg

相似文献

1
Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation.信号转导衔接蛋白2通过阻止终末效应分化促进功能性长期记忆CD8 + T细胞的产生。
Oncotarget. 2017 May 9;8(19):30766-30780. doi: 10.18632/oncotarget.15403.
2
IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.IL-27 增强了肿瘤抗原特异性 CD8+ T 细胞的存活,并将其编程为产生 IL-10 的、具有记忆前体细胞样效应细胞的功能。
Eur J Immunol. 2013 Feb;43(2):468-79. doi: 10.1002/eji.201242930. Epub 2013 Jan 15.
3
An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells.白细胞介素-21-白细胞介素-10-STAT3 通路对于记忆性 CD8+T 细胞的功能成熟至关重要。
Immunity. 2011 Nov 23;35(5):792-805. doi: 10.1016/j.immuni.2011.09.017.
4
Dok-1 and Dok-2 Regulate the Formation of Memory CD8+ T Cells.Dok-1和Dok-2调节记忆性CD8 + T细胞的形成。
J Immunol. 2016 Nov 1;197(9):3618-3627. doi: 10.4049/jimmunol.1600385. Epub 2016 Sep 23.
5
Linear differentiation of cytotoxic effectors into memory T lymphocytes.细胞毒性效应细胞向记忆性T淋巴细胞的线性分化。
Science. 1999 Mar 12;283(5408):1745-8. doi: 10.1126/science.283.5408.1745.
6
Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.信号转导子和转录激活子 3(STAT3)突变导致常染色体显性遗传高免疫球蛋白 E 综合征,损害人类 CD8(+) T 细胞记忆形成和功能。
J Allergy Clin Immunol. 2013 Aug;132(2):400-11.e9. doi: 10.1016/j.jaci.2013.05.029. Epub 2013 Jul 4.
7
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.尽管人类转移性黑色素瘤对自身抗原有抗肿瘤免疫,但肿瘤部位缺乏终末分化的肿瘤特异性CD8 + T细胞。
Cancer Res. 2003 May 15;63(10):2535-45.
8
CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.在初始阶段由 Ii-PADRE DNA 产生的 CD4+ TH1 细胞对于诱导效应器和记忆 CD8+ T 细胞非常重要。
J Immunother. 2010 Jun;33(5):510-22. doi: 10.1097/CJI.0b013e3181d75cef.
9
Complex Interplay Between MAZR and Runx3 Regulates the Generation of Cytotoxic T Lymphocyte and Memory T Cells.MAZR 和 Runx3 之间的复杂相互作用调节细胞毒性 T 淋巴细胞和记忆 T 细胞的生成。
Front Immunol. 2021 Mar 17;12:535039. doi: 10.3389/fimmu.2021.535039. eCollection 2021.
10
In vivo antitumor function of tumor antigen-specific CTLs generated in the presence of OX40 co-stimulation in vitro.体外 OX40 共刺激下生成的肿瘤抗原特异性 CTL 的体内抗肿瘤功能。
Int J Cancer. 2018 Jun 1;142(11):2335-2343. doi: 10.1002/ijc.31244. Epub 2018 Jan 21.

引用本文的文献

1
Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA.基于加权基因共表达网络分析构建预测膀胱癌生存及免疫治疗效果的T细胞耗竭模型
Front Oncol. 2023 May 30;13:1196802. doi: 10.3389/fonc.2023.1196802. eCollection 2023.
2
CD4 and CD8 regulatory T cell characterization in the rat using a unique transgenic Foxp3-EGFP model.利用独特的 Foxp3-EGFP 转基因大鼠模型鉴定 CD4 和 CD8 调节性 T 细胞。
BMC Biol. 2023 Jan 12;21(1):8. doi: 10.1186/s12915-022-01502-0.
3
The Functional Properties and Physiological Roles of Signal-Transducing Adaptor Protein-2 in the Pathogenesis of Inflammatory and Immune Disorders.

本文引用的文献

1
Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation.干扰素调节因子 4 维持 CD8(+) T 细胞的扩增和效应分化。
Immunity. 2013 Nov 14;39(5):833-45. doi: 10.1016/j.immuni.2013.10.007. Epub 2013 Nov 7.
2
The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin.皮肤 CD103(+)CD8+ 组织驻留记忆 T 细胞的发育途径。
Nat Immunol. 2013 Dec;14(12):1294-301. doi: 10.1038/ni.2744. Epub 2013 Oct 27.
3
Transcriptional regulation of effector and memory CD8+ T cell fates.
信号转导衔接蛋白2在炎症和免疫疾病发病机制中的功能特性及生理作用
Biomedicines. 2022 Nov 30;10(12):3079. doi: 10.3390/biomedicines10123079.
4
Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer.一种免疫相关风险特征的鉴定与免疫表型相关,并预测尿路上皮癌的抗PD-L1疗效。
Front Cell Dev Biol. 2021 Mar 18;9:646982. doi: 10.3389/fcell.2021.646982. eCollection 2021.
5
Signal-transducing adaptor protein-2 delays recovery of B lineage lymphocytes during hematopoietic stress.信号转导衔接蛋白-2 在造血应激期间延迟 B 谱系淋巴细胞的恢复。
Haematologica. 2021 Feb 1;106(2):424-436. doi: 10.3324/haematol.2019.225573.
效应器和记忆性 CD8+ T 细胞命运的转录调控。
Curr Opin Immunol. 2013 Jun;25(3):321-8. doi: 10.1016/j.coi.2013.05.010. Epub 2013 Jun 6.
4
Establishment of animal models to analyze the kinetics and distribution of human tumor antigen-specific CD8⁺ T cells.建立动物模型以分析人肿瘤抗原特异性 CD8⁺ T 细胞的动力学和分布。
Vaccine. 2013 Apr 19;31(17):2110-8. doi: 10.1016/j.vaccine.2013.02.056. Epub 2013 Mar 13.
5
Transcriptional control of effector and memory CD8+ T cell differentiation.效应器和记忆性 CD8+ T 细胞分化的转录控制。
Nat Rev Immunol. 2012 Nov;12(11):749-61. doi: 10.1038/nri3307. Epub 2012 Oct 19.
6
Paths to stemness: building the ultimate antitumour T cell.通向干细胞之路:构建终极抗肿瘤 T 细胞。
Nat Rev Cancer. 2012 Oct;12(10):671-84. doi: 10.1038/nrc3322. Epub 2012 Sep 21.
7
Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function.STAT5 转录因子四聚化对于细胞因子反应和正常免疫功能至关重要。
Immunity. 2012 Apr 20;36(4):586-99. doi: 10.1016/j.immuni.2012.02.017.
8
Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity.皮肤感染产生非迁移性记忆 CD8+T(RM)细胞,提供全身皮肤免疫。
Nature. 2012 Feb 29;483(7388):227-31. doi: 10.1038/nature10851.
9
A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory.STAT3 转录因子信号在人类 T 细胞记忆的发育和维持中起着关键作用。
Immunity. 2011 Nov 23;35(5):806-18. doi: 10.1016/j.immuni.2011.09.016.
10
An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells.白细胞介素-21-白细胞介素-10-STAT3 通路对于记忆性 CD8+T 细胞的功能成熟至关重要。
Immunity. 2011 Nov 23;35(5):792-805. doi: 10.1016/j.immuni.2011.09.017.